Antibody responses and protection in mice immunized orally against influenza virus

Vaccine

Volumn 14, Issue 17-18, 1996, Pages 1651-1656

  Takase, Hiroyuki ^a   Murakami, Yoichi ^a   Endo, Atsushi ^a   Ikeuchi, Tohru ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

influenza virus; mucosal immunity; oral immunization

Indexed keywords

IMMUNOGLOBULIN A; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; CHOLERA TOXIN; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINES; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; VACCINES, INACTIVATED;

EID: 0030477736     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00128-4     Document Type: Article

References (27)

1. 1 Schoenbaum, S.C. Economic impact of influenza: the individual's perspective. Am. J. Med. 1987, 82suppl. 6A, 26-30
2. 2 Murphy, B.R. and Webster, B.R. Orthomyxoviruses. In: Virology, 2nd edn (Eds Fields, B.N., Knipe, D.M., Chanock, R.M., Melnick, J.L., Roizman, B. and Shope, R.E.). Raven Press, New York, 1990, pp. 1091-1152
3. 3 Kilbourne, E.D. Inactivated influenza vaccine. In: Vaccine (Eds Plotkin, S.A. and Mortimer E.A. Jr). WB Saunders, Philadelphia, 1988, pp. 420-434
4. 4 Barber, W.H. and Small, R.A. Jr Local and systemic immunity to influenza infections in ferrets. Infect. Immun. 1978, 21, 221-228
5. 5 Ramphal, R., Cogliano, R.C., Shands, J.W. Jr and Small, P.A. Jr Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis. Infect. Immun. 1979, 25, 992-997
6. 6 McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
7. 7 Walker, R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994, 12, 387-400
8. 8 Chen, K.-S., Burlington, D.B. and Quinnan, G.V. Jr Active synthesis of hemagglutinin-specific immunogloblin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine. J. Virol. 1987, 61, 2150-2154
9. 9 Farag-Mahmod, F.I., Wyde, P.R., Rosborough, J.P. and Six, H.R. Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine 1988, 6, 262-268
10. 10 Nedrud, J.G., Liang, X., Hague, N. and Lamn, M.E. Combined oral/nasal immunization protects mice from Sendal virus infection. J. Virol. 1987, 139, 3484-3492
11. 11 Forrest, B.D., Laborooy, J.T., Dearlove, C.E. and Schearman, DJ.C. Effect of parenteral immnization on intestinal immune response to Salmonella typhi Ty21a. Infect. Immun. 1992, 68, 465-471
12. 12 Jackson, R.J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C.O. and McGhee, J.R. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 1993, 61, 4272-4279
13. 13 Kida, H., Brown, L.E. and Webster, R.G. Biological activity of monoclonal antibodies to operationally defined antigenic regions on hemagglutining molecule of A/Seal/Massachusetts/ 1/80(H7N7) influenza virus. Virology 1982, 122, 38-47
14. 14 Ichihara, K., Yamamoto, T., Kumahara, Y. and Miyai, K. An improved processing of radioimmunoassay data by means of a desk-top calculator. Comparison of regression procedures applied to selected kinds of radioimmunoassay. Clin. Chim. Acta. 1977, 79, 331
15. 15 Karberg, G. Beitrag zur kollectiven Behandlung pharmakologischer Reffienversuche. Arch. Exp. Path. Pharm. 1931, 162, 480
16. 16 Yamauchi, J. (Ed.) The Kolmogorov-Smirnov's tests. In: Statistical Tables and Formula with Computer Applications. Japanese Standards Association, Tokyo, Japan, 1972, pp. 148-153
17. 17 Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301
18. 18 Wilson, A.D., Clarke, C.J. and Stokes, C.R. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand. J. Immun. 1990, 31, 443
19. 19 Tamura, S., Yamanaka, A., Shimohara, M. et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419-426
20. 20 Hirabayashi, Y., Kurata, H., Funato, H. et al. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 1990, 8, 243-248
21. 21 Novak, M., Moldoveanu, Z., Schafer, D.P., Mestecky, J. and Compans, R.W. Murine model for evaluation of protective immunity to influenza virus. Vaccine 1993, 11, 55-60
22. 22 Clements, M., O'Donnell, S., Levine, M.M., Chanock, R.M. and Murphy, R.B. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect. Immun. 1983, 40, 1044-1051
23. 23 Tamura, S., Funato, H., Hirabayashi, Y. et al. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protectin against influenza. Vaccine 1990, 8, 479-485
24. 24 Reneger, K. and Small, P.A.Jr Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 1991, 65, 2146-2148
25. 25 Moldoveanu, Z., Novak, M., Huang, W-Q. et al. Oral immunization with influenza virus in biodegradable microspheres. J. Infect. Dis. 1993, 167, 84-90
26. 26 Keren, D.F., McDonald, R.A. and Carey, J.L. Combined parental and oral immunization results in an enhanced mucosal immunogloblin A response to Shigella flexneri. Infect. Immun. 1988, 56, 910-915
27. 27 Asanuma, H., Koide, F., Suzuki, Y. et al. Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration. Vaccine 1995, 13, 3-5